

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA deamination (GO:0045006) | 5.23967105 |
| 2 | viral transcription (GO:0019083) | 5.07535369 |
| 3 | ribosomal small subunit biogenesis (GO:0042274) | 5.00043615 |
| 4 | ribosomal small subunit assembly (GO:0000028) | 4.94472082 |
| 5 | translational termination (GO:0006415) | 4.80369889 |
| 6 | facial nerve structural organization (GO:0021612) | 4.64514082 |
| 7 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 4.45137452 |
| 8 | cotranslational protein targeting to membrane (GO:0006613) | 4.39033645 |
| 9 | protein targeting to ER (GO:0045047) | 4.35640255 |
| 10 | chromatin remodeling at centromere (GO:0031055) | 4.22555817 |
| 11 | postsynaptic membrane organization (GO:0001941) | 4.18154668 |
| 12 | CENP-A containing nucleosome assembly (GO:0034080) | 4.14545323 |
| 13 | lymphoid progenitor cell differentiation (GO:0002320) | 4.14402387 |
| 14 | protein localization to endoplasmic reticulum (GO:0070972) | 4.12888558 |
| 15 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 4.12363043 |
| 16 | respiratory chain complex IV assembly (GO:0008535) | 4.11973417 |
| 17 | DNA double-strand break processing (GO:0000729) | 4.11805015 |
| 18 | cullin deneddylation (GO:0010388) | 4.04461883 |
| 19 | negative regulation of transcription by competitive promoter binding (GO:0010944) | 4.04346688 |
| 20 | telomere maintenance via semi-conservative replication (GO:0032201) | 4.00009888 |
| 21 | presynaptic membrane assembly (GO:0097105) | 3.99835179 |
| 22 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 3.99636499 |
| 23 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 3.99636499 |
| 24 | protein deneddylation (GO:0000338) | 3.95512698 |
| 25 | regulation of pigment cell differentiation (GO:0050932) | 3.89935457 |
| 26 | synapsis (GO:0007129) | 3.88796278 |
| 27 | translational elongation (GO:0006414) | 3.80745566 |
| 28 | mannosylation (GO:0097502) | 3.79958727 |
| 29 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.72163879 |
| 30 | viral life cycle (GO:0019058) | 3.69095998 |
| 31 | protein heterotetramerization (GO:0051290) | 3.67172497 |
| 32 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.66161631 |
| 33 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.66066797 |
| 34 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.66066797 |
| 35 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.66066797 |
| 36 | histone exchange (GO:0043486) | 3.65908328 |
| 37 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.63747944 |
| 38 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.61843306 |
| 39 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.60863360 |
| 40 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.60863360 |
| 41 | maturation of SSU-rRNA (GO:0030490) | 3.60120093 |
| 42 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.56746314 |
| 43 | cranial nerve morphogenesis (GO:0021602) | 3.54776306 |
| 44 | DNA catabolic process, exonucleolytic (GO:0000738) | 3.53996057 |
| 45 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 3.53522246 |
| 46 | cellular protein complex disassembly (GO:0043624) | 3.52466347 |
| 47 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.50665074 |
| 48 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 3.50665074 |
| 49 | protein K6-linked ubiquitination (GO:0085020) | 3.49585789 |
| 50 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 3.49500419 |
| 51 | positive regulation of cellular amine metabolic process (GO:0033240) | 3.49475102 |
| 52 | ribosomal large subunit biogenesis (GO:0042273) | 3.47803106 |
| 53 | negative regulation of DNA-dependent DNA replication (GO:2000104) | 3.47728641 |
| 54 | branched-chain amino acid catabolic process (GO:0009083) | 3.46936695 |
| 55 | GPI anchor biosynthetic process (GO:0006506) | 3.43431816 |
| 56 | mesonephros development (GO:0001823) | 3.42673099 |
| 57 | prenylation (GO:0097354) | 3.42356010 |
| 58 | protein prenylation (GO:0018342) | 3.42356010 |
| 59 | regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003339 | 3.41752685 |
| 60 | protein complex biogenesis (GO:0070271) | 3.38834876 |
| 61 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 3.36534783 |
| 62 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.36123609 |
| 63 | negative regulation of ligase activity (GO:0051352) | 3.36123609 |
| 64 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.35649875 |
| 65 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.35649875 |
| 66 | NADH dehydrogenase complex assembly (GO:0010257) | 3.35649875 |
| 67 | negative regulation of myotube differentiation (GO:0010832) | 3.35358583 |
| 68 | recombinational repair (GO:0000725) | 3.34917157 |
| 69 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.33510970 |
| 70 | cranial nerve structural organization (GO:0021604) | 3.32695095 |
| 71 | cytochrome complex assembly (GO:0017004) | 3.32352892 |
| 72 | nucleobase biosynthetic process (GO:0046112) | 3.31444390 |
| 73 | double-strand break repair via homologous recombination (GO:0000724) | 3.30791597 |
| 74 | telomere maintenance via recombination (GO:0000722) | 3.30598503 |
| 75 | nephron tubule formation (GO:0072079) | 3.29705618 |
| 76 | translational initiation (GO:0006413) | 3.27609751 |
| 77 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.27569634 |
| 78 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.27502275 |
| 79 | organelle disassembly (GO:1903008) | 3.25662955 |
| 80 | purine nucleobase biosynthetic process (GO:0009113) | 3.24049645 |
| 81 | C-terminal protein lipidation (GO:0006501) | 3.23735847 |
| 82 | endothelium development (GO:0003158) | 3.23241223 |
| 83 | proteasome assembly (GO:0043248) | 3.23182899 |
| 84 | mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003337) | 3.22585719 |
| 85 | DNA ligation (GO:0006266) | 3.21965822 |
| 86 | replication fork processing (GO:0031297) | 3.21714557 |
| 87 | developmental pigmentation (GO:0048066) | 3.19976008 |
| 88 | presynaptic membrane organization (GO:0097090) | 3.19594857 |
| 89 | regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266) | 3.18569939 |
| 90 | regulation of mitotic spindle checkpoint (GO:1903504) | 3.18569939 |
| 91 | resolution of meiotic recombination intermediates (GO:0000712) | 3.18314254 |
| 92 | protein neddylation (GO:0045116) | 3.18058395 |
| 93 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.17584731 |
| 94 | response to folic acid (GO:0051593) | 3.16229593 |
| 95 | adenosine metabolic process (GO:0046085) | 3.15949868 |
| 96 | double-strand break repair via nonhomologous end joining (GO:0006303) | 3.14176774 |
| 97 | non-recombinational repair (GO:0000726) | 3.14176774 |
| 98 | DNA damage response, detection of DNA damage (GO:0042769) | 3.12420642 |
| 99 | negative regulation of metanephros development (GO:0072217) | 3.12159484 |
| 100 | GDP-mannose metabolic process (GO:0019673) | 3.11016909 |
| 101 | pattern specification involved in kidney development (GO:0061004) | 3.10383511 |
| 102 | DNA replication initiation (GO:0006270) | 3.09737678 |
| 103 | postreplication repair (GO:0006301) | 3.09580020 |
| 104 | kinetochore assembly (GO:0051382) | 3.08751217 |
| 105 | amino sugar catabolic process (GO:0046348) | 3.06756872 |
| 106 | kinetochore organization (GO:0051383) | 3.05363052 |
| 107 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.04451293 |
| 108 | protein complex disassembly (GO:0043241) | 3.02789947 |
| 109 | negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037) | 3.02719309 |
| 110 | DNA replication checkpoint (GO:0000076) | 3.02705532 |
| 111 | regulation of mitochondrial translation (GO:0070129) | 3.00752223 |
| 112 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 3.00749832 |
| 113 | platelet dense granule organization (GO:0060155) | 3.00112943 |
| 114 | DNA replication-independent nucleosome assembly (GO:0006336) | 2.99382174 |
| 115 | DNA replication-independent nucleosome organization (GO:0034724) | 2.99382174 |
| 116 | tRNA metabolic process (GO:0006399) | 2.96283994 |
| 117 | viral genome replication (GO:0019079) | 2.96263830 |
| 118 | dolichol-linked oligosaccharide biosynthetic process (GO:0006488) | 2.96056288 |
| 119 | GMP metabolic process (GO:0046037) | 2.95514380 |
| 120 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 2.95123590 |
| 121 | tRNA processing (GO:0008033) | 2.94588304 |
| 122 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 2.93419739 |
| 123 | DNA strand elongation (GO:0022616) | 2.92947917 |
| 124 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 2.92008258 |
| 125 | positive regulation of ligase activity (GO:0051351) | 2.91906812 |
| 126 | negative regulation of mesenchymal cell apoptotic process (GO:2001054) | 2.89523425 |
| 127 | metallo-sulfur cluster assembly (GO:0031163) | 2.87321542 |
| 128 | iron-sulfur cluster assembly (GO:0016226) | 2.87321542 |
| 129 | macromolecular complex disassembly (GO:0032984) | 2.82619237 |
| 130 | sympathetic nervous system development (GO:0048485) | 2.82571188 |
| 131 | histone mRNA metabolic process (GO:0008334) | 2.81712071 |
| 132 | generation of neurons (GO:0048699) | 2.81383564 |
| 133 | GPI anchor metabolic process (GO:0006505) | 2.80721613 |
| 134 | maintenance of fidelity involved in DNA-dependent DNA replication (GO:0045005) | 2.80439745 |
| 135 | peptidyl-threonine dephosphorylation (GO:0035970) | 2.80141489 |
| 136 | ribonucleoprotein complex disassembly (GO:0032988) | 2.80093799 |
| 137 | attachment of spindle microtubules to kinetochore (GO:0008608) | 2.80045910 |
| 138 | RNA phosphodiester bond hydrolysis, exonucleolytic (GO:0090503) | 2.79758136 |
| 139 | mitotic recombination (GO:0006312) | 2.79470495 |
| 140 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.79090052 |
| 141 | tRNA aminoacylation (GO:0043039) | 2.78725222 |
| 142 | amino acid activation (GO:0043038) | 2.78725222 |
| 143 | histone H2A acetylation (GO:0043968) | 2.76998549 |
| 144 | androgen biosynthetic process (GO:0006702) | 2.76601103 |
| 145 | double-strand break repair (GO:0006302) | 2.75970124 |
| 146 | DNA damage response, signal transduction by p53 class mediator (GO:0030330) | 2.75757908 |
| 147 | N-acetylneuraminate metabolic process (GO:0006054) | 2.75096109 |
| 148 | urogenital system development (GO:0001655) | 2.74241131 |
| 149 | deoxyribonucleoside triphosphate metabolic process (GO:0009200) | 2.73894582 |
| 150 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.73404246 |
| 151 | positive regulation of cell cycle arrest (GO:0071158) | 2.73140008 |
| 152 | peptidyl-histidine modification (GO:0018202) | 2.72672775 |
| 153 | translation (GO:0006412) | 2.72222556 |
| 154 | mature B cell differentiation (GO:0002335) | 2.71453182 |
| 155 | response to interferon-beta (GO:0035456) | 2.71443176 |
| 156 | signal peptide processing (GO:0006465) | 2.70329321 |
| 157 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 2.70210012 |
| 158 | mitotic G2/M transition checkpoint (GO:0044818) | 2.69771445 |
| 159 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.69229835 |
| 160 | telomere maintenance via telomere lengthening (GO:0010833) | 2.69069529 |
| 161 | tRNA methylation (GO:0030488) | 2.67937123 |
| 162 | regulation of glucokinase activity (GO:0033131) | 2.67212000 |
| 163 | regulation of hexokinase activity (GO:1903299) | 2.67212000 |
| 164 | C-terminal protein amino acid modification (GO:0018410) | 2.66628312 |
| 165 | mesenchymal to epithelial transition (GO:0060231) | 2.66213166 |
| 166 | DNA replication-dependent nucleosome assembly (GO:0006335) | 2.65968636 |
| 167 | DNA replication-dependent nucleosome organization (GO:0034723) | 2.65968636 |
| 168 | regulation of double-strand break repair via homologous recombination (GO:0010569) | 2.65194735 |
| 169 | omega-hydroxylase P450 pathway (GO:0097267) | 2.63215704 |
| 170 | protein targeting to membrane (GO:0006612) | 2.62516312 |
| 171 | fucose catabolic process (GO:0019317) | 2.60490279 |
| 172 | L-fucose metabolic process (GO:0042354) | 2.60490279 |
| 173 | L-fucose catabolic process (GO:0042355) | 2.60490279 |
| 174 | pseudouridine synthesis (GO:0001522) | 2.58524911 |
| 175 | centriole assembly (GO:0098534) | 2.58160975 |
| 176 | regulation of mesenchymal cell apoptotic process (GO:2001053) | 2.57518123 |
| 177 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.54966880 |
| 178 | termination of RNA polymerase III transcription (GO:0006386) | 2.54966880 |
| 179 | thyroid gland development (GO:0030878) | 2.53912425 |
| 180 | GTP biosynthetic process (GO:0006183) | 2.53865660 |
| 181 | nuclear-transcribed mRNA catabolic process (GO:0000956) | 2.52688914 |
| 182 | ribonucleoprotein complex biogenesis (GO:0022613) | 2.51642124 |
| 183 | phospholipid scrambling (GO:0017121) | 2.51601425 |
| 184 | neuronal action potential propagation (GO:0019227) | 2.51595095 |
| 185 | mature B cell differentiation involved in immune response (GO:0002313) | 2.50706473 |
| 186 | centriole replication (GO:0007099) | 2.48794514 |
| 187 | regulation of metanephric nephron tubule epithelial cell differentiation (GO:0072307) | 2.47831502 |
| 188 | mRNA catabolic process (GO:0006402) | 2.46152903 |
| 189 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 2.45736365 |
| 190 | mast cell activation (GO:0045576) | 2.37801572 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 6.74792036 |
| 2 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 6.26668780 |
| 3 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 3.33541189 |
| 4 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 3.16075458 |
| 5 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 3.15116637 |
| 6 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.94736029 |
| 7 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.82080872 |
| 8 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.55021526 |
| 9 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.48077076 |
| 10 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.45884414 |
| 11 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.36780367 |
| 12 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.36275619 |
| 13 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.33969530 |
| 14 | EWS_26573619_Chip-Seq_HEK293_Human | 2.24241624 |
| 15 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.20514702 |
| 16 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.15401291 |
| 17 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.14664892 |
| 18 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.13677985 |
| 19 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.10479552 |
| 20 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 2.08591205 |
| 21 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.05387217 |
| 22 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.04791337 |
| 23 | FUS_26573619_Chip-Seq_HEK293_Human | 1.98422413 |
| 24 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.97286225 |
| 25 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.96344282 |
| 26 | * HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.95384162 |
| 27 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.89886446 |
| 28 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.89460406 |
| 29 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.89102279 |
| 30 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.87794129 |
| 31 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.87038490 |
| 32 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.80859585 |
| 33 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.80710202 |
| 34 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.79485909 |
| 35 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.77563874 |
| 36 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.74055616 |
| 37 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.70250799 |
| 38 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.65965205 |
| 39 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.63302731 |
| 40 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.62889511 |
| 41 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.61663861 |
| 42 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.61532217 |
| 43 | VDR_22108803_ChIP-Seq_LS180_Human | 1.58331993 |
| 44 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.52684580 |
| 45 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.52487116 |
| 46 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.51485020 |
| 47 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.50830746 |
| 48 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.50495767 |
| 49 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.48672975 |
| 50 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.48497973 |
| 51 | * VDR_23849224_ChIP-Seq_CD4+_Human | 1.46424734 |
| 52 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.45945156 |
| 53 | P300_19829295_ChIP-Seq_ESCs_Human | 1.45469581 |
| 54 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.45134088 |
| 55 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.42250241 |
| 56 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.42137796 |
| 57 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.42131341 |
| 58 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.41334041 |
| 59 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.41287523 |
| 60 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.40606602 |
| 61 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.38835592 |
| 62 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.36771849 |
| 63 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.36476107 |
| 64 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.35394486 |
| 65 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.35126096 |
| 66 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.31496753 |
| 67 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.30875282 |
| 68 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.30161058 |
| 69 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.29130012 |
| 70 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.28990534 |
| 71 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.28281142 |
| 72 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.27866570 |
| 73 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.27629957 |
| 74 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.26801610 |
| 75 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.26435284 |
| 76 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.26164471 |
| 77 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.25444477 |
| 78 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.25381606 |
| 79 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.25184418 |
| 80 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.25101895 |
| 81 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.24164203 |
| 82 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.22227480 |
| 83 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.21746056 |
| 84 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.21549390 |
| 85 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.20406077 |
| 86 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.19622297 |
| 87 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.17833539 |
| 88 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.17349011 |
| 89 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.17137803 |
| 90 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.15966368 |
| 91 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.15405132 |
| 92 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.12242510 |
| 93 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.11683753 |
| 94 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.11395068 |
| 95 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.10127580 |
| 96 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.09142715 |
| 97 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 1.09011607 |
| 98 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.08324503 |
| 99 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.07447417 |
| 100 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.07360124 |
| 101 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.07360124 |
| 102 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.07205893 |
| 103 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.06331202 |
| 104 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.05288903 |
| 105 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.04940325 |
| 106 | * ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 1.03966984 |
| 107 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.03520675 |
| 108 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.03102108 |
| 109 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.03048279 |
| 110 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.01857909 |
| 111 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.01575497 |
| 112 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.01311385 |
| 113 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.00310395 |
| 114 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.99780773 |
| 115 | LMO2_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.99488183 |
| 116 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.99487053 |
| 117 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.98722912 |
| 118 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.98378066 |
| 119 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.98366842 |
| 120 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.97581109 |
| 121 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.96404126 |
| 122 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.96332745 |
| 123 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 0.96288505 |
| 124 | * RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.95697861 |
| 125 | P300_18555785_Chip-Seq_ESCs_Mouse | 0.95557497 |
| 126 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 0.95316708 |
| 127 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.95237210 |
| 128 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.94572823 |
| 129 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.94417218 |
| 130 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.93619194 |
| 131 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.93156703 |
| 132 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 0.93108824 |
| 133 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.92979270 |
| 134 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.92068993 |
| 135 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.92068993 |
| 136 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 0.91577905 |
| 137 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.90908718 |
| 138 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.90360383 |
| 139 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.90208357 |
| 140 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.89945322 |
| 141 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.89914498 |
| 142 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.89400451 |
| 143 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.89045531 |
| 144 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.88134739 |
| 145 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.87132285 |
| 146 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 0.87052354 |
| 147 | JUN_21703547_ChIP-Seq_K562_Human | 0.86868112 |
| 148 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.86774353 |
| 149 | MYB_26560356_Chip-Seq_TH2_Human | 0.85734496 |
| 150 | DCP1A_22483619_ChIP-Seq_HELA_Human | 0.83341233 |
| 151 | GATA3_21867929_ChIP-Seq_CD8_Mouse | 0.83081901 |
| 152 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 0.83022235 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0009379_abnormal_foot_pigmentation | 5.62019737 |
| 2 | MP0003136_yellow_coat_color | 4.68999662 |
| 3 | MP0008877_abnormal_DNA_methylation | 4.55201966 |
| 4 | MP0003806_abnormal_nucleotide_metabolis | 4.44265615 |
| 5 | MP0005409_darkened_coat_color | 4.40666943 |
| 6 | MP0001188_hyperpigmentation | 4.17621820 |
| 7 | MP0005174_abnormal_tail_pigmentation | 3.80319318 |
| 8 | MP0006292_abnormal_olfactory_placode | 3.64267906 |
| 9 | MP0006054_spinal_hemorrhage | 3.35666762 |
| 10 | MP0004381_abnormal_hair_follicle | 3.34851974 |
| 11 | MP0000015_abnormal_ear_pigmentation | 3.29407625 |
| 12 | MP0009697_abnormal_copulation | 3.09514815 |
| 13 | MP0001529_abnormal_vocalization | 2.89779334 |
| 14 | MP0003724_increased_susceptibility_to | 2.78655071 |
| 15 | MP0008057_abnormal_DNA_replication | 2.74358651 |
| 16 | MP0003787_abnormal_imprinting | 2.57610785 |
| 17 | MP0004957_abnormal_blastocyst_morpholog | 2.50499293 |
| 18 | MP0005075_abnormal_melanosome_morpholog | 2.36496430 |
| 19 | MP0003111_abnormal_nucleus_morphology | 2.35937934 |
| 20 | MP0003880_abnormal_central_pattern | 2.30301524 |
| 21 | MP0000372_irregular_coat_pigmentation | 2.29535346 |
| 22 | MP0000569_abnormal_digit_pigmentation | 2.23736737 |
| 23 | MP0001986_abnormal_taste_sensitivity | 2.21981562 |
| 24 | MP0002095_abnormal_skin_pigmentation | 2.17472611 |
| 25 | MP0006072_abnormal_retinal_apoptosis | 2.10545008 |
| 26 | MP0003121_genomic_imprinting | 2.09131309 |
| 27 | MP0008260_abnormal_autophagy | 1.99568553 |
| 28 | MP0003186_abnormal_redox_activity | 1.92124514 |
| 29 | MP0001835_abnormal_antigen_presentation | 1.80171263 |
| 30 | MP0002102_abnormal_ear_morphology | 1.79844810 |
| 31 | MP0009785_altered_susceptibility_to | 1.71901784 |
| 32 | MP0000681_abnormal_thyroid_gland | 1.69806700 |
| 33 | MP0002148_abnormal_hypersensitivity_rea | 1.68914245 |
| 34 | MP0000490_abnormal_crypts_of | 1.68617456 |
| 35 | MP0005671_abnormal_response_to | 1.67059765 |
| 36 | MP0002876_abnormal_thyroid_physiology | 1.62011374 |
| 37 | MP0003763_abnormal_thymus_physiology | 1.57052625 |
| 38 | MP0000049_abnormal_middle_ear | 1.56342748 |
| 39 | MP0000465_gastrointestinal_hemorrhage | 1.55601163 |
| 40 | MP0008932_abnormal_embryonic_tissue | 1.55201241 |
| 41 | MP0006036_abnormal_mitochondrial_physio | 1.53940337 |
| 42 | MP0003077_abnormal_cell_cycle | 1.53851948 |
| 43 | MP0006035_abnormal_mitochondrial_morpho | 1.53705719 |
| 44 | MP0002177_abnormal_outer_ear | 1.50525330 |
| 45 | MP0003938_abnormal_ear_development | 1.48775746 |
| 46 | MP0009333_abnormal_splenocyte_physiolog | 1.48081901 |
| 47 | MP0005253_abnormal_eye_physiology | 1.44755547 |
| 48 | MP0003303_peritoneal_inflammation | 1.44697898 |
| 49 | MP0005025_abnormal_response_to | 1.41201343 |
| 50 | MP0001293_anophthalmia | 1.40799615 |
| 51 | MP0002090_abnormal_vision | 1.40219352 |
| 52 | MP0003567_abnormal_fetal_cardiomyocyte | 1.40134986 |
| 53 | MP0005000_abnormal_immune_tolerance | 1.39298715 |
| 54 | MP0000566_synostosis | 1.37353043 |
| 55 | MP0003315_abnormal_perineum_morphology | 1.36667429 |
| 56 | MP0001764_abnormal_homeostasis | 1.33821491 |
| 57 | MP0002277_abnormal_respiratory_mucosa | 1.32598825 |
| 58 | MP0010234_abnormal_vibrissa_follicle | 1.30876211 |
| 59 | MP0005646_abnormal_pituitary_gland | 1.30423207 |
| 60 | MP0002751_abnormal_autonomic_nervous | 1.29562444 |
| 61 | MP0001853_heart_inflammation | 1.27887715 |
| 62 | MP0002837_dystrophic_cardiac_calcinosis | 1.27784368 |
| 63 | MP0003646_muscle_fatigue | 1.23309731 |
| 64 | MP0003252_abnormal_bile_duct | 1.23173656 |
| 65 | MP0000613_abnormal_salivary_gland | 1.22659977 |
| 66 | MP0000685_abnormal_immune_system | 1.21699441 |
| 67 | MP0002009_preneoplasia | 1.20409805 |
| 68 | MP0008058_abnormal_DNA_repair | 1.19709712 |
| 69 | MP0003436_decreased_susceptibility_to | 1.18564951 |
| 70 | MP0002420_abnormal_adaptive_immunity | 1.17986051 |
| 71 | MP0002723_abnormal_immune_serum | 1.17154262 |
| 72 | MP0002210_abnormal_sex_determination | 1.17147140 |
| 73 | MP0001819_abnormal_immune_cell | 1.16239607 |
| 74 | MP0002396_abnormal_hematopoietic_system | 1.15448067 |
| 75 | MP0002419_abnormal_innate_immunity | 1.12940822 |
| 76 | MP0002249_abnormal_larynx_morphology | 1.12614092 |
| 77 | MP0005171_absent_coat_pigmentation | 1.12255409 |
| 78 | MP0002938_white_spotting | 1.11564699 |
| 79 | MP0001800_abnormal_humoral_immune | 1.11035206 |
| 80 | MP0002452_abnormal_antigen_presenting | 1.09681340 |
| 81 | MP0005551_abnormal_eye_electrophysiolog | 1.08435133 |
| 82 | MP0001929_abnormal_gametogenesis | 1.06973939 |
| 83 | MP0000631_abnormal_neuroendocrine_gland | 1.06204954 |
| 84 | MP0002638_abnormal_pupillary_reflex | 1.05355229 |
| 85 | MP0005367_renal/urinary_system_phenotyp | 1.03107137 |
| 86 | MP0000516_abnormal_urinary_system | 1.03107137 |
| 87 | MP0003385_abnormal_body_wall | 1.02325135 |
| 88 | MP0003786_premature_aging | 1.01130715 |
| 89 | MP0003937_abnormal_limbs/digits/tail_de | 0.98035672 |
| 90 | MP0005408_hypopigmentation | 0.97921079 |
| 91 | MP0000427_abnormal_hair_cycle | 0.96917495 |
| 92 | MP0000647_abnormal_sebaceous_gland | 0.96638720 |
| 93 | MP0002398_abnormal_bone_marrow | 0.96520150 |
| 94 | MP0003879_abnormal_hair_cell | 0.96157935 |
| 95 | MP0002132_abnormal_respiratory_system | 0.95988333 |
| 96 | MP0005395_other_phenotype | 0.95094766 |
| 97 | MP0000358_abnormal_cell_content/ | 0.93030909 |
| 98 | MP0000716_abnormal_immune_system | 0.92940521 |
| 99 | MP0001919_abnormal_reproductive_system | 0.90503735 |
| 100 | MP0003693_abnormal_embryo_hatching | 0.90381858 |
| 101 | MP0002006_tumorigenesis | 0.90056639 |
| 102 | MP0000653_abnormal_sex_gland | 0.89977495 |
| 103 | MP0002160_abnormal_reproductive_system | 0.89806547 |
| 104 | MP0001119_abnormal_female_reproductive | 0.89357805 |
| 105 | MP0002166_altered_tumor_susceptibility | 0.89016501 |
| 106 | MP0001873_stomach_inflammation | 0.88456727 |
| 107 | MP0000026_abnormal_inner_ear | 0.87342644 |
| 108 | MP0001145_abnormal_male_reproductive | 0.86942143 |
| 109 | MP0001324_abnormal_eye_pigmentation | 0.86773125 |
| 110 | MP0003718_maternal_effect | 0.86689583 |
| 111 | MP0002127_abnormal_cardiovascular_syste | 0.85505182 |
| 112 | MP0001790_abnormal_immune_system | 0.84620222 |
| 113 | MP0005387_immune_system_phenotype | 0.84620222 |
| 114 | MP0001984_abnormal_olfaction | 0.84427408 |
| 115 | MP0002233_abnormal_nose_morphology | 0.83786794 |
| 116 | MP0000689_abnormal_spleen_morphology | 0.82900263 |
| 117 | MP0001663_abnormal_digestive_system | 0.82776503 |
| 118 | MP0002933_joint_inflammation | 0.80752389 |
| 119 | MP0010155_abnormal_intestine_physiology | 0.80696887 |
| 120 | MP0001697_abnormal_embryo_size | 0.80352671 |
| 121 | MP0005266_abnormal_metabolism | 0.80225975 |
| 122 | MP0004142_abnormal_muscle_tone | 0.79880424 |
| 123 | MP0003866_abnormal_defecation | 0.79016330 |
| 124 | MP0008995_early_reproductive_senescence | 0.78802250 |
| 125 | MP0002075_abnormal_coat/hair_pigmentati | 0.77835059 |
| 126 | MP0004742_abnormal_vestibular_system | 0.77327843 |
| 127 | MP0008789_abnormal_olfactory_epithelium | 0.76513270 |
| 128 | MP0010307_abnormal_tumor_latency | 0.76451356 |
| 129 | MP0005499_abnormal_olfactory_system | 0.76130841 |
| 130 | MP0005394_taste/olfaction_phenotype | 0.76130841 |
| 131 | MP0000678_abnormal_parathyroid_gland | 0.75790532 |
| 132 | MP0001186_pigmentation_phenotype | 0.75781407 |
| 133 | MP0002429_abnormal_blood_cell | 0.74798549 |
| 134 | MP0002722_abnormal_immune_system | 0.74790125 |
| 135 | MP0002405_respiratory_system_inflammati | 0.73903385 |
| 136 | MP0006276_abnormal_autonomic_nervous | 0.73470904 |
| 137 | MP0002019_abnormal_tumor_incidence | 0.72056241 |
| 138 | MP0004215_abnormal_myocardial_fiber | 0.71577272 |
| 139 | MP0005379_endocrine/exocrine_gland_phen | 0.71072857 |
| 140 | MP0005391_vision/eye_phenotype | 0.70482810 |
| 141 | MP0001963_abnormal_hearing_physiology | 0.69003773 |
| 142 | MP0003828_pulmonary_edema | 0.67692783 |
| 143 | MP0005389_reproductive_system_phenotype | 0.67659277 |
| 144 | MP0003122_maternal_imprinting | 0.67523297 |
| 145 | MP0003011_delayed_dark_adaptation | 0.67101518 |
| 146 | MP0005410_abnormal_fertilization | 0.65953163 |
| 147 | MP0003698_abnormal_male_reproductive | 0.65722341 |
| 148 | MP0005248_abnormal_Harderian_gland | 0.65529285 |
| 149 | MP0004134_abnormal_chest_morphology | 0.65334341 |
| 150 | MP0001905_abnormal_dopamine_level | 0.65195977 |
| 151 | MP0000858_altered_metastatic_potential | 0.65176280 |
| 152 | MP0003941_abnormal_skin_development | 0.64274783 |
| 153 | MP0002163_abnormal_gland_morphology | 0.62962338 |
| 154 | MP0005464_abnormal_platelet_physiology | 0.62902192 |
| 155 | MP0010678_abnormal_skin_adnexa | 0.62782931 |
| 156 | MP0001348_abnormal_lacrimal_gland | 0.62695487 |
| 157 | MP0004147_increased_porphyrin_level | 0.61878428 |
| 158 | MP0000313_abnormal_cell_death | 0.61693466 |
| 159 | MP0008875_abnormal_xenobiotic_pharmacok | 0.60871053 |
| 160 | MP0010094_abnormal_chromosome_stability | 0.60515024 |
| 161 | MP0008007_abnormal_cellular_replicative | 0.59454640 |
| 162 | MP0008873_increased_physiological_sensi | 0.59423024 |
| 163 | MP0005084_abnormal_gallbladder_morpholo | 0.59038474 |
| 164 | MP0009765_abnormal_xenobiotic_induced | 0.58970178 |
| 165 | MP0001881_abnormal_mammary_gland | 0.56522398 |
| 166 | MP0003950_abnormal_plasma_membrane | 0.54909318 |
| 167 | MP0005165_increased_susceptibility_to | 0.54386948 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Type I transferrin isoform profile (HP:0003642) | 6.72966635 |
| 2 | Reduced antithrombin III activity (HP:0001976) | 6.67096815 |
| 3 | Abnormal protein glycosylation (HP:0012346) | 4.71469199 |
| 4 | Abnormal glycosylation (HP:0012345) | 4.71469199 |
| 5 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 4.71469199 |
| 6 | Abnormal protein N-linked glycosylation (HP:0012347) | 4.71469199 |
| 7 | Abnormality of cells of the erythroid lineage (HP:0012130) | 4.36343896 |
| 8 | Abnormal number of erythroid precursors (HP:0012131) | 4.28212194 |
| 9 | Thyroid-stimulating hormone excess (HP:0002925) | 4.01993777 |
| 10 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 3.93588298 |
| 11 | Hypothermia (HP:0002045) | 3.85869002 |
| 12 | Acute necrotizing encephalopathy (HP:0006965) | 3.83839214 |
| 13 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 3.56392289 |
| 14 | Progressive macrocephaly (HP:0004481) | 3.55756716 |
| 15 | Acute encephalopathy (HP:0006846) | 3.55516665 |
| 16 | Reticulocytopenia (HP:0001896) | 3.52038259 |
| 17 | Severe visual impairment (HP:0001141) | 3.45394486 |
| 18 | Increased CSF lactate (HP:0002490) | 3.44756212 |
| 19 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 3.41534168 |
| 20 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.41506858 |
| 21 | Abnormality of the axillary hair (HP:0100134) | 3.34278374 |
| 22 | Abnormality of secondary sexual hair (HP:0009888) | 3.34278374 |
| 23 | Increased hepatocellular lipid droplets (HP:0006565) | 3.33085046 |
| 24 | Abnormality of the labia minora (HP:0012880) | 3.31989013 |
| 25 | Nonprogressive disorder (HP:0003680) | 3.15988643 |
| 26 | Renal Fanconi syndrome (HP:0001994) | 3.04058630 |
| 27 | Methylmalonic acidemia (HP:0002912) | 3.02265341 |
| 28 | Attenuation of retinal blood vessels (HP:0007843) | 2.87292588 |
| 29 | Exertional dyspnea (HP:0002875) | 2.84116322 |
| 30 | Abnormal biliary tract physiology (HP:0012439) | 2.78013773 |
| 31 | Bile duct proliferation (HP:0001408) | 2.78013773 |
| 32 | Macrocytic anemia (HP:0001972) | 2.75675528 |
| 33 | Abnormal sex determination (HP:0012244) | 2.71721276 |
| 34 | Sex reversal (HP:0012245) | 2.71721276 |
| 35 | Cerebral edema (HP:0002181) | 2.68742640 |
| 36 | Molar tooth sign on MRI (HP:0002419) | 2.64720671 |
| 37 | Abnormality of midbrain morphology (HP:0002418) | 2.64720671 |
| 38 | Lipid accumulation in hepatocytes (HP:0006561) | 2.64461593 |
| 39 | Abnormality of magnesium homeostasis (HP:0004921) | 2.64189735 |
| 40 | Pallor (HP:0000980) | 2.61094332 |
| 41 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.58962139 |
| 42 | Increased serum lactate (HP:0002151) | 2.58427196 |
| 43 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.56442862 |
| 44 | Posterior subcapsular cataract (HP:0007787) | 2.54455227 |
| 45 | 3-Methylglutaconic aciduria (HP:0003535) | 2.53103353 |
| 46 | Medial flaring of the eyebrow (HP:0010747) | 2.52390421 |
| 47 | Colon cancer (HP:0003003) | 2.50969592 |
| 48 | Aplastic anemia (HP:0001915) | 2.50601329 |
| 49 | Obstructive lung disease (HP:0006536) | 2.49894387 |
| 50 | Chronic obstructive pulmonary disease (HP:0006510) | 2.49894387 |
| 51 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.48961785 |
| 52 | Neoplasm of the adrenal gland (HP:0100631) | 2.47214702 |
| 53 | Methylmalonic aciduria (HP:0012120) | 2.45616040 |
| 54 | Stomatitis (HP:0010280) | 2.44107790 |
| 55 | Increased serum pyruvate (HP:0003542) | 2.43331753 |
| 56 | Hepatocellular necrosis (HP:0001404) | 2.42497808 |
| 57 | Split foot (HP:0001839) | 2.41829610 |
| 58 | True hermaphroditism (HP:0010459) | 2.41792629 |
| 59 | Meningitis (HP:0001287) | 2.36178016 |
| 60 | Flat occiput (HP:0005469) | 2.33187803 |
| 61 | Type 2 muscle fiber atrophy (HP:0003554) | 2.32017474 |
| 62 | Nephronophthisis (HP:0000090) | 2.31374415 |
| 63 | Dry hair (HP:0011359) | 2.31244287 |
| 64 | Lactic acidosis (HP:0003128) | 2.30339507 |
| 65 | Bifid tongue (HP:0010297) | 2.28850824 |
| 66 | Abnormal spermatogenesis (HP:0008669) | 2.28702063 |
| 67 | Cortical visual impairment (HP:0100704) | 2.28256283 |
| 68 | Intestinal atresia (HP:0011100) | 2.26976066 |
| 69 | Azoospermia (HP:0000027) | 2.26563526 |
| 70 | Abnormality of glycolysis (HP:0004366) | 2.22645069 |
| 71 | Muscle fiber atrophy (HP:0100295) | 2.21575787 |
| 72 | Prolonged partial thromboplastin time (HP:0003645) | 2.15637421 |
| 73 | Abnormality of chromosome stability (HP:0003220) | 2.15203702 |
| 74 | B lymphocytopenia (HP:0010976) | 2.12852957 |
| 75 | Abnormality of methionine metabolism (HP:0010901) | 2.12778208 |
| 76 | Microvesicular hepatic steatosis (HP:0001414) | 2.10073732 |
| 77 | Increased intramyocellular lipid droplets (HP:0012240) | 2.09659112 |
| 78 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 2.08831595 |
| 79 | Microcytic anemia (HP:0001935) | 2.08806593 |
| 80 | Respiratory failure (HP:0002878) | 2.08664701 |
| 81 | Abnormality of the columella (HP:0009929) | 2.07945515 |
| 82 | Thrombocytosis (HP:0001894) | 2.07386822 |
| 83 | Abnormality of B cell number (HP:0010975) | 2.07333741 |
| 84 | Renal cortical cysts (HP:0000803) | 2.06859135 |
| 85 | Leukodystrophy (HP:0002415) | 2.06773283 |
| 86 | Neoplasm of the adrenal cortex (HP:0100641) | 2.06041739 |
| 87 | CNS demyelination (HP:0007305) | 2.04779573 |
| 88 | Thyroiditis (HP:0100646) | 2.04237137 |
| 89 | IgM deficiency (HP:0002850) | 2.03615152 |
| 90 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.01922856 |
| 91 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 2.01666575 |
| 92 | Abnormality of the prostate (HP:0008775) | 2.01178042 |
| 93 | Petechiae (HP:0000967) | 2.00412301 |
| 94 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.00237942 |
| 95 | Abnormality of the renal medulla (HP:0100957) | 2.00157950 |
| 96 | Abnormality of the ileum (HP:0001549) | 1.99659511 |
| 97 | Myositis (HP:0100614) | 1.98930873 |
| 98 | Respiratory difficulties (HP:0002880) | 1.98483477 |
| 99 | Mitochondrial inheritance (HP:0001427) | 1.96772331 |
| 100 | Abnormality of renal resorption (HP:0011038) | 1.96686279 |
| 101 | Median cleft lip (HP:0000161) | 1.96099773 |
| 102 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.95519361 |
| 103 | Ocular albinism (HP:0001107) | 1.93288158 |
| 104 | Parakeratosis (HP:0001036) | 1.92982996 |
| 105 | Patchy hypopigmentation of hair (HP:0011365) | 1.92470834 |
| 106 | Recurrent abscess formation (HP:0002722) | 1.92312215 |
| 107 | Abnormality of the preputium (HP:0100587) | 1.86812168 |
| 108 | Thoracic kyphosis (HP:0002942) | 1.85710259 |
| 109 | Congenital primary aphakia (HP:0007707) | 1.85321777 |
| 110 | Chromsome breakage (HP:0040012) | 1.84081038 |
| 111 | Pancreatic fibrosis (HP:0100732) | 1.83047978 |
| 112 | Hepatic necrosis (HP:0002605) | 1.82329975 |
| 113 | Pancreatic cysts (HP:0001737) | 1.81476339 |
| 114 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.81066555 |
| 115 | Abnormality of the renal cortex (HP:0011035) | 1.80467033 |
| 116 | Neoplasm of the peripheral nervous system (HP:0100007) | 1.80373919 |
| 117 | Severe combined immunodeficiency (HP:0004430) | 1.79690440 |
| 118 | Lethargy (HP:0001254) | 1.79332802 |
| 119 | Hypoplasia of the radius (HP:0002984) | 1.79230598 |
| 120 | Optic disc pallor (HP:0000543) | 1.79037185 |
| 121 | Abnormality of lateral ventricle (HP:0030047) | 1.77989602 |
| 122 | Rectal fistula (HP:0100590) | 1.77648581 |
| 123 | Rectovaginal fistula (HP:0000143) | 1.77648581 |
| 124 | Mediastinal lymphadenopathy (HP:0100721) | 1.76750288 |
| 125 | Progressive microcephaly (HP:0000253) | 1.76247808 |
| 126 | Abnormality of vitamin B metabolism (HP:0004340) | 1.76070566 |
| 127 | Anencephaly (HP:0002323) | 1.75888606 |
| 128 | Agammaglobulinemia (HP:0004432) | 1.75331377 |
| 129 | Capillary hemangiomas (HP:0005306) | 1.75190709 |
| 130 | Decreased central vision (HP:0007663) | 1.75167242 |
| 131 | Hypomagnesemia (HP:0002917) | 1.74722367 |
| 132 | Clubbing of toes (HP:0100760) | 1.74392878 |
| 133 | Pulmonary fibrosis (HP:0002206) | 1.73182127 |
| 134 | Genital tract atresia (HP:0001827) | 1.71045612 |
| 135 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 1.69823168 |
| 136 | Male pseudohermaphroditism (HP:0000037) | 1.69173989 |
| 137 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 1.68989344 |
| 138 | Hypoplasia of the fovea (HP:0007750) | 1.68989344 |
| 139 | Abnormal lung lobation (HP:0002101) | 1.68453844 |
| 140 | Nephrogenic diabetes insipidus (HP:0009806) | 1.67890250 |
| 141 | Prolonged bleeding time (HP:0003010) | 1.66420955 |
| 142 | Sloping forehead (HP:0000340) | 1.66410959 |
| 143 | Progressive inability to walk (HP:0002505) | 1.66176464 |
| 144 | Absent septum pellucidum (HP:0001331) | 1.64844172 |
| 145 | Hyperglycinuria (HP:0003108) | 1.64721546 |
| 146 | White forelock (HP:0002211) | 1.64491814 |
| 147 | Aplasia/Hypoplasia involving the musculature (HP:0001460) | 1.64105998 |
| 148 | Abnormality of the septum pellucidum (HP:0007375) | 1.63900635 |
| 149 | Volvulus (HP:0002580) | 1.63771988 |
| 150 | Iris hypopigmentation (HP:0007730) | 1.63705684 |
| 151 | Dicarboxylic aciduria (HP:0003215) | 1.63106765 |
| 152 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.63106765 |
| 153 | Abnormality of the metopic suture (HP:0005556) | 1.62554282 |
| 154 | Lower limb hyperreflexia (HP:0002395) | 1.62486338 |
| 155 | Optic nerve hypoplasia (HP:0000609) | 1.61960043 |
| 156 | Adrenal hypoplasia (HP:0000835) | 1.61646943 |
| 157 | Abnormality of DNA repair (HP:0003254) | 1.61575961 |
| 158 | Short tibia (HP:0005736) | 1.61462246 |
| 159 | Hypoproteinemia (HP:0003075) | 1.61413146 |
| 160 | Triphalangeal thumb (HP:0001199) | 1.61387171 |
| 161 | Chronic otitis media (HP:0000389) | 1.60045828 |
| 162 | Pancytopenia (HP:0001876) | 1.60013611 |
| 163 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.59777084 |
| 164 | Abnormality of alanine metabolism (HP:0010916) | 1.59777084 |
| 165 | Hyperalaninemia (HP:0003348) | 1.59777084 |
| 166 | Meckel diverticulum (HP:0002245) | 1.58562452 |
| 167 | Supernumerary spleens (HP:0009799) | 1.58117508 |
| 168 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.57173218 |
| 169 | Recurrent cutaneous fungal infections (HP:0011370) | 1.57173218 |
| 170 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 1.57166190 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TNIK | 6.65147200 |
| 2 | EIF2AK3 | 4.43205832 |
| 3 | MKNK2 | 3.95826897 |
| 4 | MUSK | 3.88548594 |
| 5 | STK16 | 3.48579174 |
| 6 | CASK | 3.38421396 |
| 7 | NLK | 2.91360875 |
| 8 | TRIM28 | 2.83113619 |
| 9 | NME2 | 2.80528535 |
| 10 | MKNK1 | 2.69902831 |
| 11 | FRK | 2.60441597 |
| 12 | NEK1 | 2.52507078 |
| 13 | TLK1 | 2.30482049 |
| 14 | IRAK3 | 2.28708274 |
| 15 | IRAK4 | 2.23575104 |
| 16 | CAMKK2 | 2.22604531 |
| 17 | FES | 2.17613083 |
| 18 | CCNB1 | 2.14244426 |
| 19 | MAP4K2 | 1.95337260 |
| 20 | BLK | 1.85110323 |
| 21 | EIF2AK2 | 1.83709291 |
| 22 | TEC | 1.77229233 |
| 23 | PLK3 | 1.66847822 |
| 24 | CDK19 | 1.66298349 |
| 25 | VRK2 | 1.58451390 |
| 26 | SRPK1 | 1.44962191 |
| 27 | VRK1 | 1.40725963 |
| 28 | PINK1 | 1.40541915 |
| 29 | BRSK2 | 1.40015176 |
| 30 | TTK | 1.35802038 |
| 31 | ERBB3 | 1.34129739 |
| 32 | WNK3 | 1.34038287 |
| 33 | PIM2 | 1.33604934 |
| 34 | KIT | 1.33414354 |
| 35 | BCKDK | 1.30052267 |
| 36 | YES1 | 1.29915180 |
| 37 | WEE1 | 1.27798679 |
| 38 | TSSK6 | 1.21509258 |
| 39 | PLK2 | 1.12368438 |
| 40 | CLK1 | 1.11404911 |
| 41 | TXK | 1.10122341 |
| 42 | IRAK2 | 1.10014754 |
| 43 | TAF1 | 1.10013547 |
| 44 | PLK1 | 1.09968525 |
| 45 | STK38L | 1.09701456 |
| 46 | STK39 | 1.08990862 |
| 47 | RPS6KA4 | 1.07420483 |
| 48 | ADRBK2 | 1.06282415 |
| 49 | MST4 | 1.04934251 |
| 50 | CAMK1 | 1.02114561 |
| 51 | STK3 | 1.01374578 |
| 52 | PDK2 | 1.00758680 |
| 53 | MAP2K7 | 1.00053368 |
| 54 | PAK3 | 0.99527783 |
| 55 | IRAK1 | 0.99517347 |
| 56 | BTK | 0.98626177 |
| 57 | MAP3K4 | 0.97992016 |
| 58 | ATR | 0.97662978 |
| 59 | BCR | 0.97524782 |
| 60 | PNCK | 0.95153807 |
| 61 | DYRK3 | 0.94178754 |
| 62 | PRPF4B | 0.88920515 |
| 63 | CSNK1G2 | 0.85884464 |
| 64 | MAPK13 | 0.81462008 |
| 65 | MAP3K12 | 0.80887263 |
| 66 | IKBKB | 0.78139153 |
| 67 | SCYL2 | 0.77808575 |
| 68 | PRKD2 | 0.76044019 |
| 69 | LYN | 0.72453280 |
| 70 | DAPK1 | 0.71143766 |
| 71 | IKBKE | 0.69973440 |
| 72 | RIPK4 | 0.68563001 |
| 73 | MAP4K1 | 0.67492284 |
| 74 | BMPR1B | 0.66961347 |
| 75 | LATS1 | 0.66124886 |
| 76 | HIPK2 | 0.64183026 |
| 77 | CHEK2 | 0.64037279 |
| 78 | WNK4 | 0.63499101 |
| 79 | MAPKAPK5 | 0.63411256 |
| 80 | SYK | 0.63234146 |
| 81 | CDK7 | 0.61278449 |
| 82 | MAPKAPK3 | 0.58969840 |
| 83 | ACVR1B | 0.58685232 |
| 84 | CDK3 | 0.58487526 |
| 85 | GRK1 | 0.58266472 |
| 86 | BRD4 | 0.57821593 |
| 87 | CSNK1G1 | 0.57657405 |
| 88 | MINK1 | 0.57154114 |
| 89 | SIK3 | 0.56207021 |
| 90 | CSF1R | 0.55501080 |
| 91 | LCK | 0.53504603 |
| 92 | MAP3K14 | 0.53502463 |
| 93 | KDR | 0.52888301 |
| 94 | MAPK4 | 0.52307909 |
| 95 | ATM | 0.51787863 |
| 96 | PRKG2 | 0.51197087 |
| 97 | ZAK | 0.50897559 |
| 98 | RPS6KA5 | 0.50448779 |
| 99 | GRK7 | 0.50441145 |
| 100 | TNK2 | 0.50314304 |
| 101 | PASK | 0.45771869 |
| 102 | PBK | 0.45423967 |
| 103 | BUB1 | 0.44315994 |
| 104 | MAP3K5 | 0.44168259 |
| 105 | TGFBR1 | 0.43344067 |
| 106 | EIF2AK1 | 0.42227965 |
| 107 | CSK | 0.42224171 |
| 108 | MAPK15 | 0.41734641 |
| 109 | CSNK1G3 | 0.41281462 |
| 110 | FLT3 | 0.39919779 |
| 111 | CAMK2B | 0.39714294 |
| 112 | PIM1 | 0.38242336 |
| 113 | HCK | 0.38129919 |
| 114 | BMPR2 | 0.37467384 |
| 115 | ERBB4 | 0.37430941 |
| 116 | DYRK2 | 0.37114334 |
| 117 | UHMK1 | 0.36601079 |
| 118 | CSNK1A1 | 0.36559887 |
| 119 | FER | 0.35697772 |
| 120 | CDK14 | 0.34640896 |
| 121 | ALK | 0.34313237 |
| 122 | ZAP70 | 0.33698039 |
| 123 | DYRK1A | 0.33611104 |
| 124 | STK4 | 0.33602511 |
| 125 | EGFR | 0.33285060 |
| 126 | CSNK2A2 | 0.32223905 |
| 127 | CHEK1 | 0.32018798 |
| 128 | MATK | 0.31273294 |
| 129 | RAF1 | 0.30249871 |
| 130 | CSNK2A1 | 0.30071615 |
| 131 | PLK4 | 0.28907765 |
| 132 | PIK3CG | 0.28200000 |
| 133 | FGR | 0.27344296 |
| 134 | CSNK1A1L | 0.25875590 |
| 135 | NUAK1 | 0.24577041 |
| 136 | CDK8 | 0.24470752 |
| 137 | OXSR1 | 0.21384319 |
| 138 | TGFBR2 | 0.20571019 |
| 139 | TBK1 | 0.20340188 |
| 140 | CDC7 | 0.20045595 |
| 141 | CDK4 | 0.19262964 |
| 142 | AURKB | 0.19247448 |
| 143 | TIE1 | 0.19117413 |
| 144 | RPS6KB2 | 0.19085925 |
| 145 | ABL1 | 0.18991779 |
| 146 | PRKAA2 | 0.18407565 |
| 147 | CAMK4 | 0.17000068 |
| 148 | TAOK3 | 0.16262943 |
| 149 | PRKG1 | 0.15683309 |
| 150 | TYK2 | 0.15682400 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ribosome_Homo sapiens_hsa03010 | 4.65734531 |
| 2 | DNA replication_Homo sapiens_hsa03030 | 3.63187864 |
| 3 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.94463148 |
| 4 | Protein export_Homo sapiens_hsa03060 | 2.66823090 |
| 5 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 2.64960978 |
| 6 | Homologous recombination_Homo sapiens_hsa03440 | 2.58708897 |
| 7 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 2.39997572 |
| 8 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.31325024 |
| 9 | Mismatch repair_Homo sapiens_hsa03430 | 2.30400878 |
| 10 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 2.21765792 |
| 11 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 2.15481907 |
| 12 | RNA polymerase_Homo sapiens_hsa03020 | 2.08042276 |
| 13 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.05142917 |
| 14 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.92047837 |
| 15 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.90935559 |
| 16 | Other glycan degradation_Homo sapiens_hsa00511 | 1.80887110 |
| 17 | Spliceosome_Homo sapiens_hsa03040 | 1.79233662 |
| 18 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.78907099 |
| 19 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.77271385 |
| 20 | Base excision repair_Homo sapiens_hsa03410 | 1.75073200 |
| 21 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.72550753 |
| 22 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.71192399 |
| 23 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.55094300 |
| 24 | Basal transcription factors_Homo sapiens_hsa03022 | 1.45399920 |
| 25 | Phototransduction_Homo sapiens_hsa04744 | 1.45352628 |
| 26 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.44558798 |
| 27 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.41235873 |
| 28 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.38460261 |
| 29 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.36838259 |
| 30 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.35929792 |
| 31 | Proteasome_Homo sapiens_hsa03050 | 1.33809038 |
| 32 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.33622902 |
| 33 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.32868820 |
| 34 | Allograft rejection_Homo sapiens_hsa05330 | 1.28669103 |
| 35 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.26228661 |
| 36 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.25599605 |
| 37 | Purine metabolism_Homo sapiens_hsa00230 | 1.24253834 |
| 38 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.23825626 |
| 39 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.22965154 |
| 40 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.22753685 |
| 41 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.22085628 |
| 42 | Asthma_Homo sapiens_hsa05310 | 1.21733482 |
| 43 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.20220956 |
| 44 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.20017260 |
| 45 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.18415769 |
| 46 | Thyroid cancer_Homo sapiens_hsa05216 | 1.17320285 |
| 47 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.15855211 |
| 48 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.12922822 |
| 49 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.09346509 |
| 50 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.07465221 |
| 51 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.05723501 |
| 52 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.05519497 |
| 53 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.04757786 |
| 54 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.04344798 |
| 55 | Peroxisome_Homo sapiens_hsa04146 | 1.03818003 |
| 56 | Measles_Homo sapiens_hsa05162 | 1.01134352 |
| 57 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.00876603 |
| 58 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.99751778 |
| 59 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.98932619 |
| 60 | Malaria_Homo sapiens_hsa05144 | 0.98529429 |
| 61 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.96320867 |
| 62 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.96221634 |
| 63 | RNA degradation_Homo sapiens_hsa03018 | 0.92151148 |
| 64 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.91879468 |
| 65 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.89712124 |
| 66 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.89710149 |
| 67 | Sulfur relay system_Homo sapiens_hsa04122 | 0.86860306 |
| 68 | Parkinsons disease_Homo sapiens_hsa05012 | 0.85400493 |
| 69 | Leishmaniasis_Homo sapiens_hsa05140 | 0.83236770 |
| 70 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.80196711 |
| 71 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.78507917 |
| 72 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.77525081 |
| 73 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.76444848 |
| 74 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.73883560 |
| 75 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.72883569 |
| 76 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.72599977 |
| 77 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.71340529 |
| 78 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.71203367 |
| 79 | Alzheimers disease_Homo sapiens_hsa05010 | 0.70699231 |
| 80 | Huntingtons disease_Homo sapiens_hsa05016 | 0.70344803 |
| 81 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.69934547 |
| 82 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.68280467 |
| 83 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.65267980 |
| 84 | Alcoholism_Homo sapiens_hsa05034 | 0.62370454 |
| 85 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.61989979 |
| 86 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.59076284 |
| 87 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.58485300 |
| 88 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.58174681 |
| 89 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.56683957 |
| 90 | Pertussis_Homo sapiens_hsa05133 | 0.54535531 |
| 91 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.54153306 |
| 92 | Cell cycle_Homo sapiens_hsa04110 | 0.53448574 |
| 93 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.52714444 |
| 94 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.51236711 |
| 95 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.51011000 |
| 96 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.49422228 |
| 97 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.49114515 |
| 98 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.48345607 |
| 99 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.48010054 |
| 100 | Carbon metabolism_Homo sapiens_hsa01200 | 0.47261806 |
| 101 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.46434250 |
| 102 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.46398799 |
| 103 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.45888940 |
| 104 | Olfactory transduction_Homo sapiens_hsa04740 | 0.43908187 |
| 105 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.43076243 |
| 106 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.42810595 |
| 107 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.42411916 |
| 108 | RNA transport_Homo sapiens_hsa03013 | 0.41285506 |
| 109 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.41228834 |
| 110 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.39480484 |
| 111 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.39306036 |
| 112 | Nicotine addiction_Homo sapiens_hsa05033 | 0.39239570 |
| 113 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.38149055 |
| 114 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.37792746 |
| 115 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.37586206 |
| 116 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.37042190 |
| 117 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.36974682 |
| 118 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.35543771 |
| 119 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.34606721 |
| 120 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.33989784 |
| 121 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.33595855 |
| 122 | Tuberculosis_Homo sapiens_hsa05152 | 0.33491937 |
| 123 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.33304597 |
| 124 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.32063849 |
| 125 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.31894800 |
| 126 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.31408399 |
| 127 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.31290078 |
| 128 | Metabolic pathways_Homo sapiens_hsa01100 | 0.31233113 |
| 129 | Salmonella infection_Homo sapiens_hsa05132 | 0.30475418 |
| 130 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.30312589 |
| 131 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.30279522 |
| 132 | Taste transduction_Homo sapiens_hsa04742 | 0.29098958 |
| 133 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.28922983 |
| 134 | Influenza A_Homo sapiens_hsa05164 | 0.28609743 |
| 135 | Hepatitis B_Homo sapiens_hsa05161 | 0.28324662 |
| 136 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.28127771 |
| 137 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.28101657 |
| 138 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.26660406 |
| 139 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.25206774 |
| 140 | Shigellosis_Homo sapiens_hsa05131 | 0.24242261 |
| 141 | Legionellosis_Homo sapiens_hsa05134 | 0.23913390 |
| 142 | Retinol metabolism_Homo sapiens_hsa00830 | 0.21854618 |

